Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.

Moeini A, Torrecilla S, Tovar V, Montironi C, Andreu-Oller C, Peix J, Higuera M, Pfister D, Ramadori P, Pinyol R, Solé M, Heikenwälder M, Friedman SL, Sia D, Llovet JM.

Gastroenterology. 2019 Jul 22. pii: S0016-5085(19)41121-9. doi: 10.1053/j.gastro.2019.07.028. [Epub ahead of print]

PMID:
31344396
2.

Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials.

Montal R, Andreu-Oller C, Bassaganyas L, Esteban-Fabró R, Moran S, Montironi C, Moeini A, Pinyol R, Peix J, Cabellos L, Villanueva A, Sia D, Mazzaferro V, Esteller M, Llovet JM.

Br J Cancer. 2019 Aug;121(4):340-343. doi: 10.1038/s41416-019-0513-7. Epub 2019 Jul 9.

PMID:
31285588
3.

β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma.

Ruiz de Galarreta M, Bresnahan E, Molina-Sánchez P, Lindblad KE, Maier B, Sia D, Puigvehi M, Miguela V, Casanova-Acebes M, Dhainaut M, Villacorta-Martin C, Singhi AD, Moghe A, von Felden J, Tal Grinspan L, Wang S, Kamphorst AO, Monga SP, Brown BD, Villanueva A, Llovet JM, Merad M, Lujambio A.

Cancer Discov. 2019 Aug;9(8):1124-1141. doi: 10.1158/2159-8290.CD-19-0074. Epub 2019 Jun 11.

PMID:
31186238
4.

"Medial Epicondyle Fracture leading to Snapping Elbow with Ulnar Neuropathy".

Agrawal S, Sia D.

Am J Phys Med Rehabil. 2019 Feb 19. doi: 10.1097/PHM.0000000000001164. [Epub ahead of print] No abstract available.

PMID:
30801263
5.

Immune Exclusion-Wnt/CTNNB1 Class Predicts Resistance to Immunotherapies in HCC.

Pinyol R, Sia D, Llovet JM.

Clin Cancer Res. 2019 Apr 1;25(7):2021-2023. doi: 10.1158/1078-0432.CCR-18-3778. Epub 2019 Jan 7.

PMID:
30617138
6.

Elbow Myositis Ossificans: Radiographic Evolution With Histologic Correlation.

Lim YT, Hallinan JTPD, Sia DSY.

Am J Phys Med Rehabil. 2019 Jul;98(7):e88-e89. doi: 10.1097/PHM.0000000000001100. No abstract available.

PMID:
30461430
7.

A "BREACH" Too Far: Exertional Rhabdomyolysis in the Elbow Flexor Muscles.

Lim LK, Sia DSY, Hallinan JTPD, Zhang J.

Am J Phys Med Rehabil. 2019 Jul;98(7):e86-e87. doi: 10.1097/PHM.0000000000001086. No abstract available.

PMID:
30365399
8.

Spinal Gout-Dual-Energy CT for Noninvasive Diagnosis.

Soon BKH, Sia DSY, Zhang J.

J Clin Rheumatol. 2018 Sep 27. doi: 10.1097/RHU.0000000000000903. [Epub ahead of print] No abstract available.

PMID:
30273263
9.

Sequelae of bilateral luxatio erecta in the acute post-reduction period demonstrated by MRI: a case report and literature review.

Ngam PI, Hallinan JT, Sia DSY.

Skeletal Radiol. 2019 Mar;48(3):467-473. doi: 10.1007/s00256-018-3047-9. Epub 2018 Aug 27. Review.

PMID:
30151632
10.

Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial.

Pinyol R, Montal R, Bassaganyas L, Sia D, Takayama T, Chau GY, Mazzaferro V, Roayaie S, Lee HC, Kokudo N, Zhang Z, Torrecilla S, Moeini A, Rodriguez-Carunchio L, Gane E, Verslype C, Croitoru AE, Cillo U, de la Mata M, Lupo L, Strasser S, Park JW, Camps J, Solé M, Thung SN, Villanueva A, Pena C, Meinhardt G, Bruix J, Llovet JM.

Gut. 2019 Jun;68(6):1065-1075. doi: 10.1136/gutjnl-2018-316408. Epub 2018 Aug 14.

11.

Molecular therapies and precision medicine for hepatocellular carcinoma.

Llovet JM, Montal R, Sia D, Finn RS.

Nat Rev Clin Oncol. 2018 Oct;15(10):599-616. doi: 10.1038/s41571-018-0073-4. Review.

PMID:
30061739
12.

Immune privilege: failure of immunotherapy in controlling metastatic cutaneous melanoma to the eye.

Sia DIT, Thaung C, O'Hanlon-Brown C, Cohen VML, Sagoo MS.

Melanoma Res. 2018 Aug;28(4):359-362. doi: 10.1097/CMR.0000000000000443.

PMID:
29634634
13.

A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma.

Labgaa I, Villacorta-Martin C, D'Avola D, Craig AJ, von Felden J, Martins-Filho SN, Sia D, Stueck A, Ward SC, Fiel MI, Mahajan M, Tabrizian P, Thung SN, Ang C, Friedman SL, Llovet JM, Schwartz M, Villanueva A.

Oncogene. 2018 Jul;37(27):3740-3752. doi: 10.1038/s41388-018-0206-3. Epub 2018 Apr 9.

14.

Saphenous Nerve Block From Within the Knee Is Feasible for TKA: MRI and Cadaveric Study.

Kavolus JJ, Sia D, Potter HG, Attarian DE, Lachiewicz PF.

Clin Orthop Relat Res. 2018 Jan;476(1):30-36. doi: 10.1007/s11999.0000000000000006.

15.

Recap of the Knee Cap: A "Leave Alone" Lesion.

Zhang J, Sia DS, Singh G, Singbal SB, Hallinan JTP.

Ann Acad Med Singapore. 2017 Oct;46(10):410-412. No abstract available.

16.

Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma.

Torrecilla S, Sia D, Harrington AN, Zhang Z, Cabellos L, Cornella H, Moeini A, Camprecios G, Leow WQ, Fiel MI, Hao K, Bassaganyas L, Mahajan M, Thung SN, Villanueva A, Florman S, Schwartz ME, Llovet JM.

J Hepatol. 2017 Dec;67(6):1222-1231. doi: 10.1016/j.jhep.2017.08.013. Epub 2017 Aug 24.

17.

Liver cancer: Translating '-omics' results into precision medicine for hepatocellular carcinoma.

Sia D, Llovet JM.

Nat Rev Gastroenterol Hepatol. 2017 Oct;14(10):571-572. doi: 10.1038/nrgastro.2017.103. Epub 2017 Aug 2. No abstract available.

PMID:
28765583
18.

Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.

Sia D, Jiao Y, Martinez-Quetglas I, Kuchuk O, Villacorta-Martin C, Castro de Moura M, Putra J, Camprecios G, Bassaganyas L, Akers N, Losic B, Waxman S, Thung SN, Mazzaferro V, Esteller M, Friedman SL, Schwartz M, Villanueva A, Llovet JM.

Gastroenterology. 2017 Sep;153(3):812-826. doi: 10.1053/j.gastro.2017.06.007. Epub 2017 Jun 15.

19.

Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.

Moeini A, Sia D, Zhang Z, Camprecios G, Stueck A, Dong H, Montal R, Torrens L, Martinez-Quetglas I, Fiel MI, Hao K, Villanueva A, Thung SN, Schwartz ME, Llovet JM.

J Hepatol. 2017 May;66(5):952-961. doi: 10.1016/j.jhep.2017.01.010. Epub 2017 Jan 23.

20.

Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference.

Abou-Alfa GK, Andersen JB, Chapman W, Choti M, Forbes SJ, Gores GJ, Hong TS, Harding JJ, Vander Heiden MG, Javle M, Kelley RK, Kwong LN, Lowery M, Merrell A, Miyabe K, Rhim A, Saha S, Sia D, Tanasanvimon S, Venook A, Valle JW, Walesky C, Whetstine J, Willenbring H, Zhu AX, Mayer D, Stanger BZ.

J Gastrointest Oncol. 2016 Dec;7(6):819-827. doi: 10.21037/jgo.2016.11.11. No abstract available.

21.

Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.

Sia D, Villanueva A, Friedman SL, Llovet JM.

Gastroenterology. 2017 Mar;152(4):745-761. doi: 10.1053/j.gastro.2016.11.048. Epub 2016 Dec 30. Review.

22.

Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma.

Bollard J, Miguela V, Ruiz de Galarreta M, Venkatesh A, Bian CB, Roberto MP, Tovar V, Sia D, Molina-Sánchez P, Nguyen CB, Nakagawa S, Llovet JM, Hoshida Y, Lujambio A.

Gut. 2017 Jul;66(7):1286-1296. doi: 10.1136/gutjnl-2016-312268. Epub 2016 Nov 14.

23.

The role of transportation to access maternal care services for women in rural Bangladesh and Burkina Faso: A mixed methods study.

Alam N, Chowdhury ME, Kouanda S, Seppey M, Alam A, Savadogo JR, Sia D, Fournier P.

Int J Gynaecol Obstet. 2016 Nov;135 Suppl 1:S45-S50. doi: 10.1016/j.ijgo.2016.09.003.

PMID:
27836084
24.

What explains gender inequalities in HIV/AIDS prevalence in sub-Saharan Africa? Evidence from the demographic and health surveys.

Sia D, Onadja Y, Hajizadeh M, Heymann SJ, Brewer TF, Nandi A.

BMC Public Health. 2016 Nov 3;16(1):1136.

25.

Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis.

Moran S, Martínez-Cardús A, Sayols S, Musulén E, Balañá C, Estival-Gonzalez A, Moutinho C, Heyn H, Diaz-Lagares A, de Moura MC, Stella GM, Comoglio PM, Ruiz-Miró M, Matias-Guiu X, Pazo-Cid R, Antón A, Lopez-Lopez R, Soler G, Longo F, Guerra I, Fernandez S, Assenov Y, Plass C, Morales R, Carles J, Bowtell D, Mileshkin L, Sia D, Tothill R, Tabernero J, Llovet JM, Esteller M.

Lancet Oncol. 2016 Oct;17(10):1386-1395. doi: 10.1016/S1470-2045(16)30297-2. Epub 2016 Aug 27.

PMID:
27575023
26.

Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma.

Tovar V, Cornella H, Moeini A, Vidal S, Hoshida Y, Sia D, Peix J, Cabellos L, Alsinet C, Torrecilla S, Martinez-Quetglas I, Lozano JJ, Desbois-Mouthon C, Solé M, Domingo-Domenech J, Villanueva A, Llovet JM.

Gut. 2017 Mar;66(3):530-540. doi: 10.1136/gutjnl-2015-309501. Epub 2015 Dec 11.

27.

Intravitreal Triamcinolone Deposition Mimicking Frosted Branch Angiitis: Optical Coherence Tomography Findings.

Sia DI, Durkin S.

Retina. 2016 Jun;36(6):e41-2. doi: 10.1097/IAE.0000000000000928. No abstract available.

PMID:
26655615
28.

Evolution of gout: "malignant" change over time?

Eide SE, Khor YM, Seet JE, Sia DS.

J Radiol Case Rep. 2015 Oct 31;9(10):35-46. doi: 10.3941/jrcr.v9i10.2571. eCollection 2015 Oct.

29.

Corrigendum: Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer.

Saha SK, Parachoniak CA, Ghanta KS, Fitamant J, Ross KN, Najem MS, Gurumurthy S, Akbay EA, Sia D, Cornella H, Miltiadous O, Walesky C, Deshpande V, Zhu AX, Hezel AF, Yen KE, Straley KS, Travins J, Popovici-Muller J, Gliser C, Ferrone CR, Apte U, Llovet JM, Wong KK, Ramaswamy S, Bardeesy N.

Nature. 2015 Dec 3;528(7580):152. doi: 10.1038/nature16136. Epub 2015 Nov 18. No abstract available.

PMID:
26580013
30.

Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma.

Moeini A, Sia D, Bardeesy N, Mazzaferro V, Llovet JM.

Clin Cancer Res. 2016 Jan 15;22(2):291-300. doi: 10.1158/1078-0432.CCR-14-3296. Epub 2015 Sep 24. Review.

31.

The future of patient-derived tumor xenografts in cancer treatment.

Sia D, Moeini A, Labgaa I, Villanueva A.

Pharmacogenomics. 2015;16(14):1671-83. doi: 10.2217/pgs.15.102. Epub 2015 Sep 24. Review.

PMID:
26402657
32.

Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation.

Miltiadous O, Sia D, Hoshida Y, Fiel MI, Harrington AN, Thung SN, Tan PS, Dong H, Revill K, Chang CY, Roayaie S, Byrne TJ, Mazzaferro V, Rakela J, Florman S, Schwartz M, Llovet JM.

J Hepatol. 2015 Dec;63(6):1368-77. doi: 10.1016/j.jhep.2015.07.025. Epub 2015 Jul 26.

33.

Nerve Fiber Layer Infarcts in Thiamine Deficiency.

Sia PI, Sia DI, Crompton JL, Casson RJ.

J Neuroophthalmol. 2015 Sep;35(3):274-6. doi: 10.1097/WNO.0000000000000243.

PMID:
25815858
34.

YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression.

Fitamant J, Kottakis F, Benhamouche S, Tian HS, Chuvin N, Parachoniak CA, Nagle JM, Perera RM, Lapouge M, Deshpande V, Zhu AX, Lai A, Min B, Hoshida Y, Avruch J, Sia D, Campreciós G, McClatchey AI, Llovet JM, Morrissey D, Raj L, Bardeesy N.

Cell Rep. 2015 Mar 17;10(10):1692-1707. doi: 10.1016/j.celrep.2015.02.027. Epub 2015 Mar 12.

35.

Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma.

Sia D, Losic B, Moeini A, Cabellos L, Hao K, Revill K, Bonal D, Miltiadous O, Zhang Z, Hoshida Y, Cornella H, Castillo-Martin M, Pinyol R, Kasai Y, Roayaie S, Thung SN, Fuster J, Schwartz ME, Waxman S, Cordon-Cardo C, Schadt E, Mazzaferro V, Llovet JM.

Nat Commun. 2015 Jan 22;6:6087. doi: 10.1038/ncomms7087.

36.

Creating a digital retinoscope by combining a mobile smartphone camera and a retinoscope.

Chan WO, Crabb M, Sia D, Taranath D.

J AAPOS. 2014 Aug;18(4):387-8. doi: 10.1016/j.jaapos.2014.03.012.

PMID:
25173904
37.

Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer.

Saha SK, Parachoniak CA, Ghanta KS, Fitamant J, Ross KN, Najem MS, Gurumurthy S, Akbay EA, Sia D, Cornella H, Miltiadous O, Walesky C, Deshpande V, Zhu AX, Hezel AF, Yen KE, Straley KS, Travins J, Popovici-Muller J, Gliser C, Ferrone CR, Apte U, Llovet JM, Wong KK, Ramaswamy S, Bardeesy N.

Nature. 2014 Sep 4;513(7516):110-4. doi: 10.1038/nature13441. Epub 2014 Jul 2. Erratum in: Nature. 2015 Dec 3;528(7580):152.

38.

Re-envisioning global agricultural trade: time for a paradigm shift to ensure food security and population health in low-income countries.

Pirkle CM, Poliquin H, Sia D, Kouakou KJ, Sagna T.

Glob Health Promot. 2015 Mar;22(1):60-3. doi: 10.1177/1757975914531029. Epub 2014 May 9.

PMID:
24814860
39.

Socioeconomic inequalities in HIV/AIDS prevalence in sub-Saharan African countries: evidence from the Demographic Health Surveys.

Hajizadeh M, Sia D, Heymann SJ, Nandi A.

Int J Equity Health. 2014 Feb 18;13:18. doi: 10.1186/1475-9276-13-18.

40.

What lies behind gender inequalities in HIV/AIDS in sub-Saharan African countries: evidence from Kenya, Lesotho and Tanzania.

Sia D, Onadja Y, Nandi A, Foro A, Brewer T.

Health Policy Plan. 2014 Oct;29(7):938-49. doi: 10.1093/heapol/czt075. Epub 2013 Dec 17.

41.

Increasing institutional deliveries among antenatal clients: effect of birth preparedness counselling.

Soubeiga D, Sia D, Gauvin L.

Health Policy Plan. 2014 Dec;29(8):1061-70. doi: 10.1093/heapol/czt089. Epub 2013 Nov 22.

42.

General anaesthetic considerations for haemostasis in orbital surgery.

Sia DI, Chalmers A, Singh V, Malhotra R, Selva D.

Orbit. 2014 Feb;33(1):5-12. doi: 10.3109/01676830.2013.842250. Epub 2013 Oct 21. Review.

PMID:
24144180
43.

Orbital compartment syndrome following transvenous embolization of carotid-cavernous fistula.

Sia PI, Sia DI, Scroop R, Selva D.

Orbit. 2014 Feb;33(1):52-4. doi: 10.3109/01676830.2013.841717. Epub 2013 Oct 21.

PMID:
24144159
44.

VEGF signaling in cancer treatment.

Sia D, Alsinet C, Newell P, Villanueva A.

Curr Pharm Des. 2014;20(17):2834-42. Review.

PMID:
23944367
45.

[Birth preparedness in antenatal care: effects of health center characteristics].

Soubeiga D, Sia D.

Rev Epidemiol Sante Publique. 2013 Aug;61(4):299-310. doi: 10.1016/j.respe.2012.12.019. Epub 2013 Jun 27. French.

PMID:
23810629
46.
47.

Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies.

Sia D, Tovar V, Moeini A, Llovet JM.

Oncogene. 2013 Oct 10;32(41):4861-70. doi: 10.1038/onc.2012.617. Epub 2013 Jan 14. Review.

48.

Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.

Sia D, Hoshida Y, Villanueva A, Roayaie S, Ferrer J, Tabak B, Peix J, Sole M, Tovar V, Alsinet C, Cornella H, Klotzle B, Fan JB, Cotsoglou C, Thung SN, Fuster J, Waxman S, Garcia-Valdecasas JC, Bruix J, Schwartz ME, Beroukhim R, Mazzaferro V, Llovet JM.

Gastroenterology. 2013 Apr;144(4):829-40. doi: 10.1053/j.gastro.2013.01.001. Epub 2013 Jan 4.

49.

Polypoidal choroidal vasculopathy: naked polyp.

Sia DI, Ebneter A, Sinkar S, Gilhotra J.

Int Ophthalmol. 2013 Feb;33(1):67-9. doi: 10.1007/s10792-012-9681-7. Epub 2012 Nov 25.

PMID:
23183910
50.

Perspective on ophthalmic support in countries of the developing world.

Muecke J, Sia DI, Newland H, Casson RJ, Selva D.

Clin Exp Ophthalmol. 2013 Apr;41(3):263-71. doi: 10.1111/j.1442-9071.2012.02869.x. Epub 2012 Oct 30. Review.

PMID:
22958085

Supplemental Content

Support Center